Mind & Spirit
Invest in companies transforming mental healthcare through innovative treatments and technologies. These carefully selected stocks represent leaders in psychedelic therapeutics, telehealth platforms, and neurological treatments addressing the growing global demand for mental wellness solutions.
Top Picks from This Group
Here are a few of the assets in this group. Create an account to unlock the full list.
About This Group of Stocks
Our Expert Thinking
This collection targets the rapidly expanding mental health market by focusing on companies developing breakthrough treatments and technologies. From novel psychedelic compounds to telehealth services, these stocks represent the future of brain and emotional wellness in an increasingly destigmatized field.
What You Need to Know
This portfolio blends emerging biotechs with established medical companies creating next-generation mental health treatments. The group benefits from powerful trends including regulatory evolution, virtual care adoption, and growing acceptance of alternative therapies for psychological conditions.
Why These Stocks
We've handpicked companies with clear missions to advance mental healthcare through innovation. This selection includes both pioneering startups developing novel compounds and established firms with strong market positions, all poised to address large, underserved patient populations.
12 Month Growth Potential
Use the growth calculator to see how much investing in these assets could return over one year.
If you invested across these assets:
in 12 months it could be worth:
+265.01%
Group Performance Snapshot
Average 12 Month Profit
On average, analysts expect assets in this group to grow 265.01% over the next year.
Stocks Rated Buy by Analysts
11 of 14 assets in this group are rated Buy by professional analysts.
Group Growth
This group averaged a 3.3% return last month.
Why You'll Want to Watch These Stocks
Breaking Mental Health Barriers
These companies are pioneering treatments once considered impossible, creating therapies that could help millions with treatment-resistant conditions like severe depression and PTSD.
Regulatory Winds Shifting
A fundamental change in how regulators view novel therapeutics is quickly unlocking massive new markets, especially for previously restricted compounds showing promise for mental health.
The Next Healthcare Revolution
Mental health is becoming as important as physical health, with spending expected to surge as stigma fades and innovative digital platforms make treatment more accessible than ever before.
Why Invest with Nemo Money?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
Discover More Opportunities
Uncle Sam's Semiconductor Stake
The U.S. government is considering an equity stake in Intel to boost domestic semiconductor manufacturing. This strategic move could create a ripple effect, benefiting other American companies involved in the chip-making industry.
The Cybersecurity Consolidation Wave
Accenture's record-breaking acquisition of CyberCX signals a major consolidation trend in the cybersecurity sector. This move highlights the growing demand for AI-powered security solutions, creating potential opportunities for other specialized cybersecurity firms to benefit from increased investment and M&A activity.
American Chipmakers: A Tariff-Driven Shift
President Trump has threatened to impose tariffs of up to 300% on semiconductors to boost domestic production. This creates a potential investment opportunity in U.S.-based semiconductor companies that stand to gain from a shift toward onshore manufacturing.
Frequently Asked Questions
Everything you need to know about the product and billing.